On October 3, 2016, the 19th participant completed their long-term (12-month) follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD …
WASHINGTON, D.C. — Today, the Drug Enforcement Administration (DEA) announced their intention to grant licenses to additional marijuana growers for research, thereby ending the DEA-imposed 48-year monopoly …
On March 24, 2016, the final open label experimental treatment session was completed in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. In addition to being the final experimental …
On January 21 and February 26, 2016, the 17th and 18th participants completed their 12-month long-term follow-up interviews in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, …
On February 5, 2016, the 23rd and final participant had their two-month follow-up evaluation in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD in …
On January 31, 2016, the tenth and final subject received their last blinded experimental treatment session in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. In addition to being the …
On January 13, 2016, the tenth and final subject received their first treatment in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this …
As of December 16, 2015, 12 long-term follow-up interviews have been completed for participants in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD. …
On December 10, 2015, the ninth participant was treated in our Israeli study of MDMA-assisted psychotherapy for PTSD. The tenth and final participant was enrolled on December 16. Led by Principal Investigator …
On December 4, 2015, the last subject received their final experimental treatment in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD. This study …
On November 4, 2015, the ninth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 study will treat …
On November 2, 2015, enrollment was concluded in our study of MDMA-assisted psychotherapy for PTSD from sexual assault, violent crime, military service, or any other cause, taking place in Vancouver, Canada. …
